city New Delhi covid-19 infection medicines patient city New Delhi

Govt restricts sale of crucial Covid-19 medicines as cases mount

Reading now: 714
www.livemint.com

NEW DELHI: With the number of Covid-19 cases and deaths rising across the country, the government has taken steps to restrict the sale and distribution of anti-malarial drug hydroxychloroquine and anti-HIV combination drug lopinavir and ritonavir that, according to anecdotal evidence, can be re-purposed to treat the disease.

In a notification late Thursday, the health ministry marked anti-malarial medicine hydroxychloroquine as a Schedule H1 drug to restrict its sale and distribution to prevent misuse.

The notification by the health ministry followed another by the National Pharmaceutical Pricing Authority dated Wednesday which directed manufacturers of the fixed drug combination of lopinavir and ritonavir to maintain a stock level of at

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA